Wagner S. Brum
@wagnersbrum
MD-PhD student working with Alzheimer's disease biomarkers and their clinical interpretation at @goteborgsuni @ufrgsnoticias @zimmerneurolab
ID: 1025383450377957376
https://scholar.google.com/citations?hl=en&user=g0CSvU8AAAAJ 03-08-2018 14:10:40
1,1K Tweet
1,1K Followers
978 Following
Excited to share this collaborative work with Nicolas Villain / Moved to LinkedIn & BlueSky now published in Alzheimer's & Dementia. In this study, we reanalyzed the NACC neuropathologic data used in the 2024 Revised Criteria for the Diagnosis and Staging of Alzheimerās Disease. alz-journals.onlinelibrary.wiley.com/doi/pdf/10.100ā¦
Biologists, stop putting UMAP plots in your papers! UMAP is a powerful tool for exploratory data analysis, but without a clear understanding of how it works, it can easily lead to confusion and misinterpretation. Link to Simply Statistics blogpost below.
āDiagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathologyā from Nicholas Ashton, Wagner S. Brum & colleagues as the most read 2024 article in JAMA Neurology
Happy to share this study led by Benedetta Bigio Carla Nasca lab NYU Langone Health and our team UFRJ just published molecularpsychiatry. Here, using two cohorts, we show that plasma carnitine levels are reduced in women with cognitive impairment and dementia. nature.com/articles/s4138ā¦
Always my favourite post at the beginning of the year: Registration for our course āBiomarkers for neurodegenerative diseasesā is now open! This yearās edition takes place at UCL Queen Square Institute of Neurology in central London on May 12-16. biomarker-course.org
šØ Open PhD Position šØ I am looking to hire a doctoral student for a fully funded PhD position focused on understanding the role of neuroinflammation and synaptic loss in Alzheimerās disease and other proteinopathies with novel PET imaging biomarkers/kidoktorand.varbi.com/en/what:job/joā¦
šØ New Study just out in The Lancet Global Health š§ Lucas Da Ros, Wyllians Borelli, Cristiano Schaffer Aguzzoli & colleagues used a machine learning model to determine the most important risk factors for cognitive and functional decline in Brazil and other Latin American Countries š§¶1š thelancet.com/journals/langlā¦
New *open access* paper in Alzheimer's & Dementia Journals ā with the Alzheimer's Association #GBSC we compared 33 different plasma p-tau assays. TLDR ā Plasma p-tau217 on several platforms was the best at discriminating Alzheimerās from controls alz-journals.onlinelibrary.wiley.com/doi/10.1002/alā¦
Check out our plasma p-tau round robin study! Just published at Alzheimer's & Dementia Journals
and now the paper is out... pubmed.ncbi.nlm.nih.gov/39907496/ š£ 33 different ways to measure #blood #pTau šMass Spec, semi & fully-auto immunoassays š©ø#pTau217 consistently best šCorr. between #pTau217 assays = optimism for standardisation Jonathan Schott Ashvini Keshavan Wagner S. Brum
Thrilled to be back home at BarcelonaĪ²eta Brain Research Center as the Lead of the Neuroimaging Group! š Even better, we have a PhD position open to work with PET & MRI imaging in early stages of #Alzheimerās. If you know someone passionate about neuroimaging, please shareš barcelonabeta.org/es/centro-inveā¦
š Congratulations to our PhD student Giovanna Carello-Collar for receiving the AAIC Neuroscience Next āOne to Watchā Award at #AAICNeuro šŗšø! A well-deserved recognition by the Alzheimer's Association for her contributions to neuroscience research. šāØ
I am very honored to have my work recognized by the AAIC Neuroscience Next! Thank you to all my mentors, colleagues, and friends who have been incredibly supportive along the way. Alzheimer's Association Gƶteborgs universitet / University of Gothenburg
